206 related articles for article (PubMed ID: 32924324)
1. In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells.
Gamperl S; Stefanzl G; Willmann M; Valent P; Hadzijusufovic E
Vet Med Sci; 2021 Jan; 7(1):57-68. PubMed ID: 32924324
[TBL] [Abstract][Full Text] [Related]
2. H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.
Hadzijusufovic E; Peter B; Gleixner KV; Schuch K; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Mirkina I; Willmann M; Valent P
Exp Hematol; 2010 Oct; 38(10):896-907. PubMed ID: 20570632
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1.
Queralt M; Brazís P; Merlos M; de Mora F; Puigdemont A
Inflamm Res; 2000 Jul; 49(7):355-60. PubMed ID: 10959557
[TBL] [Abstract][Full Text] [Related]
4. Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
Gamperl S; Stefanzl G; Peter B; Smiljkovic D; Bauer K; Willmann M; Valent P; Hadzijusufovic E
Vet Comp Oncol; 2019 Dec; 17(4):553-561. PubMed ID: 31286638
[TBL] [Abstract][Full Text] [Related]
5. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
6. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
García G; DeMora F; Ferrer L; Puigdemont A
Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
[TBL] [Abstract][Full Text] [Related]
7. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
Vasiadi M; Kalogeromitros D; Kempuraj D; Clemons A; Zhang B; Chliva C; Makris M; Wolfberg A; House M; Theoharides TC
Int Arch Allergy Immunol; 2010; 151(1):38-45. PubMed ID: 19672095
[TBL] [Abstract][Full Text] [Related]
8. Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells.
Krauth MT; Majlesi Y; Sonneck K; Samorapoompichit P; Ghannadan M; Hauswirth AW; Baghestanian M; Schernthaner GH; Worda C; Müller MR; Sperr WR; Valent P
Allergy; 2006 Mar; 61(3):281-8. PubMed ID: 16436135
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
Church MK; Hiroi J
Br J Pharmacol; 1987 Feb; 90(2):421-9. PubMed ID: 2435353
[TBL] [Abstract][Full Text] [Related]
10. Antiallergic activity of loratadine, a non-sedating antihistamine.
Kreutner W; Chapman RW; Gulbenkian A; Siegel MI
Allergy; 1987 Jan; 42(1):57-63. PubMed ID: 2436504
[TBL] [Abstract][Full Text] [Related]
11. Esomeprazole induces structural changes and apoptosis and alters function of in vitro canine neoplastic mast cells.
Gould EN; Szule JA; Wilson-Robles H; Steiner JM; Lennon EM; Tolbert MK
Vet Immunol Immunopathol; 2023 Feb; 256():110539. PubMed ID: 36592548
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation.
Rozniecki JJ; Letourneau R; Sugiultzoglu M; Spanos C; Gorbach J; Theoharides TC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1427-35. PubMed ID: 10454522
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells.
Sperr WR; Agis H; Czerwenka K; Virgolini I; Bankl HC; Müller MR; Zsebo K; Lechner K; Valent P
J Allergy Clin Immunol; 1996 Aug; 98(2):389-99. PubMed ID: 8757216
[TBL] [Abstract][Full Text] [Related]
14. Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells.
Martin RK; Saleem SJ; Folgosa L; Zellner HB; Damle SR; Nguyen GK; Ryan JJ; Bear HD; Irani AM; Conrad DH
J Leukoc Biol; 2014 Jul; 96(1):151-9. PubMed ID: 24610880
[TBL] [Abstract][Full Text] [Related]
15. NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation.
Hadzijusufovic E; Peter B; Herrmann H; Rülicke T; Cerny-Reiterer S; Schuch K; Kenner L; Thaiwong T; Yuzbasiyan-Gurkan V; Pickl WF; Willmann M; Valent P
Allergy; 2012 Jul; 67(7):858-68. PubMed ID: 22583069
[TBL] [Abstract][Full Text] [Related]
16. [Loratadine inhibits mediator liberation from a suspension of human pulmonary mast cells].
Peters SP
Allerg Immunol (Paris); 1991 Mar; 23(3):109. PubMed ID: 1712595
[No Abstract] [Full Text] [Related]
17. Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils.
Krauth MT; Böhm A; Agis H; Sonneck K; Samorapoompichit P; Florian S; Sotlar K; Valent P
Exp Hematol; 2007 Jan; 35(1):108-16. PubMed ID: 17198879
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
Okayama Y; Benyon RC; Lowman MA; Church MK
Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Antonijoan R; Coimbra J; García-Gea C; Puntes M; Gich I; Campo C; Valiente R; Labeaga L
Curr Med Res Opin; 2017 Jan; 33(1):129-136. PubMed ID: 27659218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
